Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Colorcon
Daiichi Sankyo
Moodys
Teva
Dow
Cipla
Healthtrust
Queensland Health
AstraZeneca

Generated: February 25, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,722,021

« Back to Dashboard

Summary for Patent: 8,722,021
Title:Foamable carriers
Abstract: The invention relates to an alcohol-free cosmetic or therapeutic foam carrier comprising water, a hydrophobic organic carrier, a foam adjuvant agent, a surface-active agent and a gelling agent. The cosmetic or therapeutic foam carrier does not contain aliphatic alcohols, making it non-irritating and non-drying. The alcohol-free foam carrier is suitable for inclusion of both water-soluble and oil soluble therapeutic and cosmetic agents.
Inventor(s): Friedman; Doron (Karmei Yosef, IL), Besonov; Alex (Rehovot, IL), Tamarkin; Dov (Ness Ziona, IL), Eini; Meir (Ness Ziona, IL)
Assignee: Foamix Ltd. (Rehovot, IL)
Application Number:13/786,902
Patent Claim Types:
see list of patent claims
Composition; Use;

Drugs Protected by US Patent 8,722,021

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Bayer Hlthcare FINACEA azelaic acid AEROSOL, FOAM;TOPICAL 207071-001 Jul 29, 2015 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 8,722,021

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Israel152486Oct 25, 2002

Non-Orange Book US Patents Family Members for Patent 8,722,021

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,539,208 Foam prepared from nanoemulsions and uses ➤ Sign Up
8,703,105 Oleaginous pharmaceutical and cosmetic foam ➤ Sign Up
8,840,869 Body cavity foams ➤ Sign Up
2,010,040,561 ➤ Sign Up
7,704,518 Foamable vehicle and pharmaceutical compositions thereof ➤ Sign Up
8,362,091 Foamable vehicle and pharmaceutical compositions thereof ➤ Sign Up
9,211,259 Antibiotic kit and composition and uses thereof ➤ Sign Up
8,900,554 Foamable composition and uses thereof ➤ Sign Up
8,518,378 Oleaginous pharmaceutical and cosmetic foam ➤ Sign Up
9,682,021 Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 8,722,021

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Israel 187277 ➤ Sign Up
Israel 187276 ➤ Sign Up
Israel 186923 ➤ Sign Up
Israel 187275 ➤ Sign Up
Israel 173095 ➤ Sign Up
Israel 173094 ➤ Sign Up
Israel 173093 ➤ Sign Up
Israel 173092 ➤ Sign Up
Israel 168399 ➤ Sign Up
Hong Kong 1175403 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Express Scripts
Teva
Johnson and Johnson
Cerilliant
Federal Trade Commission
Deloitte
AstraZeneca
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot